Form 4 for ONC BeOne Medicines Ltd.
Accepted 2025-03-13 00:00:00 ET · period of report 2025-03-11 · accession 0001651308-25-000050 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-13 | 2025-03-11 | ONC | Wang Xiaodong | Dir, COB, Scientific Advisory Brd | G - Gift | $0.00 | -158.7K | 5.08M | -3% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2025-03-11 | G | D | 158,717 | $0.00 | 5,082,165 | D | — | — | (F1) Bona fide gift(s) of shares which are exempt from Section 16(b) of the Securities Exchange Act pursuant to Rule 16b-5. |